Future research in the field of MDM2 aims to develop more effective and specific inhibitors, understand the mechanisms underlying resistance, and identify biomarkers for patient stratification. Additionally, combining MDM2 inhibitors with other therapeutic modalities, such as immunotherapy and chemotherapy, holds potential for enhancing treatment efficacy. Advances in understanding the complex regulatory networks involving MDM2 will pave the way for novel therapeutic strategies and improve outcomes for cancer patients.
